MSC Industrial Direct (MSM)
NYSEIndustrialsIndustrial - DistributionSnapshot 2026-09-04
$121.41+2.99%
Close 2026-09-04 · 1-day change
NYSEIndustrialsIndustrial - DistributionSnapshot 2026-09-04
QuarterlyIQ Insights · MSM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 3,908.7 | 3,769.5 | 3,821.0 | 3,691.9 | — | 3,243.2 | 3,192.4 | 3,363.8 | 3,203.9 | 2,887.7 | 2,863.5 | 2,910.4 | 2,787.1 | 2,457.6 | 2,355.9 | 2,021.8 |
| Total Revenues | — | — | — | — | — | — | — | 3,363.8 | 3,203.9 | 2,887.7 | 2,863.5 | 2,910.4 | 2,787.1 | 2,457.6 | 2,355.9 | 2,021.8 |
| Cost of Revenues | 2,313.1 | 2,233.4 | 2,248.2 | 2,133.6 | — | 1,909.7 | 1,849.1 | 1,931.8 | 1,810.9 | 1,601.5 | 1,574.6 | 1,593.8 | 1,500.9 | 1,339.1 | 1,277.7 | 1,080.9 |
| Gross Profit | 1,595.6 | 1,536.1 | 1,572.8 | 1,558.2 | — | 1,333.5 | 1,343.3 | 1,432.0 | 1,393.0 | 1,286.2 | 1,288.9 | 1,316.6 | 1,286.3 | 1,118.5 | 1,078.2 | 940.9 |
| Operating Expenses & Income | ||||||||||||||||
| Operating Income | 332.1 | 301.6 | 390.4 | 468.7 | — | 301.8 | 350.7 | 400.0 | 420.6 | 379.0 | 376.0 | 379.5 | 383.2 | 385.5 | 412.2 | 349.8 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 24.1 | 25.8 | 17.6 | — | 14.5 | 16.7 | 16.9 | 14.5 | 12.4 | 5.8 | 6.3 | 3.9 | 2.2 | 0.2 | 0.3 |
| Interest & Investment Income | 0.7 | 1.1 | 0.4 | 0.2 | — | 0.1 | 0.3 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.4 | 0.1 | 0.2 | 0.1 |
| Net Interest Expenses | — | — | — | 17.4 | — | 14.4 | 16.3 | 16.4 | 13.8 | 11.7 | 5.2 | 5.6 | 3.5 | 2.0 | 0.0 | 0.2 |
| Other Non-Operating Income / Expenses | (28.2) | (38.0) | (47.6) | (17.6) | — | (13.4) | (16.5) | (16.9) | (14.4) | (11.0) | (4.2) | (6.4) | (3.7) | (2.1) | (0.1) | (0.4) |
| Asset Writedown | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | 0.0 |
| EBT, Incl. Unusual Items | 303.9 | 263.6 | 342.7 | 451.1 | — | 288.4 | 334.3 | 383.1 | 406.2 | 368.0 | 371.7 | 373.1 | 379.5 | 383.4 | 412.1 | 349.3 |
| Income Tax Expense | 75.8 | 65.7 | 86.8 | 110.7 | — | 70.4 | 82.5 | 94.3 | 77.0 | 136.6 | 140.5 | 141.8 | 143.5 | 145.4 | 153.1 | 130.5 |
| Net Income | ||||||||||||||||
| Minority Interest | (3.1) | (1.5) | (2.6) | 0.7 | — | 1.0 | 0.6 | (0.1) | — | — | — | — | — | — | — | — |
| Net Income | 231.2 | 199.3 | 258.6 | 339.8 | — | 216.9 | 251.1 | 288.9 | 329.2 | 231.4 | 231.2 | 231.3 | 236.1 | 238.0 | 259.0 | 218.8 |
| Per Share | ||||||||||||||||
| Basic EPS | 4.14 | 3.57 | 4.60 | 6.09 | — | 3.89 | 4.53 | 5.23 | 5.84 | 4.08 | 3.78 | 3.75 | 3.78 | 3.77 | 4.12 | 3.45 |
| Diluted EPS | 4.13 | 3.57 | 4.58 | 6.06 | — | 3.87 | 4.51 | 5.20 | 5.80 | 4.05 | 3.77 | 3.74 | 3.76 | 3.75 | 4.09 | 3.43 |
| Revenue per Share | 69.81 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | — | 2.22 | 1.80 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 55.8 | 55.8 | 56.3 | 55.8 | — | 55.7 | 55.5 | 55.2 | 56.4 | 56.6 | 60.9 | 61.3 | 62.0 | 62.7 | 62.4 | 62.9 |
| Diluted Weighted Avg Shares | 56.0 | 55.9 | 56.4 | 56.0 | — | 56.1 | 55.6 | 55.5 | 56.7 | 57.0 | 61.1 | 61.5 | 62.3 | 63.0 | 62.8 | 63.3 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 392.2 | 471.3 | 539.1 | — | 370.6 | 419.8 | 465.4 | 483.7 | 442.0 | 447.9 | 449.3 | 448.1 | 435.0 | 446.9 | 378.9 |
| EBIT | 332.1 | 301.6 | 390.4 | 468.7 | — | 301.8 | 350.7 | 400.0 | 420.6 | 379.0 | 376.0 | 379.5 | 383.2 | 385.5 | 412.2 | 349.8 |
| Effective Tax Rate | 24.9% | — | — | 24.5% | — | 24.4% | 24.7% | 24.6% | 18.9% | 37.1% | 37.8% | 38.0% | 37.8% | 37.9% | 37.2% | 37.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.